Employment and work forceYou are hereOur regionEconomy and businessEconomic environmentEmployment and work force
Surveys have shown that the average employee, usually qualified, active in Western Switzerland is known for the quality of his or her work. Identification with the company is very strong and, overall, the Swiss employee speaks several languages, has a good knowledge of world markets and an excellent education adapted to the needs of a competitive economy. Employees’ legal protection and the social conditions in force ensure comfort and security, also guaranteeing the company excellent levels of productivity.
Recent surveys conducted by the famous International Institute for Management Development (IMD) show that Switzerland occupies the first rank in terms of yearly working hours (40 to 42 hours per week, ahead of all the European countries and the United States), as well as the highest motivation index in the world and the most flexible legal conditions for companies.
The costs pertaining to employment are shared out into salaries, on the one hand, and into social security contributions on the other hand. These are shared out into three pension programmes, the so-called "three pillars", the conditions of which favour both the employee and the employer, who bear the charges on the basis of 50 % each.
All the citizens of the European Union (EU) and of the countries that are members of the European Free Trade Association (EFTA) can work in Switzerland under privileged conditions thanks to the bilateral agreements. The system of work permits that depends on the employee’s nationality was conceived to favour the exchange of competences and moves within companies that are essential for success.
BioAlps World Visibitlity Package 201918.03.2019A yearly international programme for our affiliated companies to increase their visibility.
"Bristol-Myers Squibb to Acquire Celgene for About Billion""The combined company will have nine products with more than billion in annual sales"
Eclosion2 & cie SCPCInvestor, Public / Bank / Venture Capital FundsEclosion & cie SCPC is a life science investment fund focusing on translating cutting edge science into biotechnology companies developing transformational best-in-diseases therapeutics and platform technologies.
We are builders. Eclosion's approach is defined by its unique entrepreneurial mindset leading to a strong operational and investment commitment to start-up enterprises. Eclosion is driven by an experienced management team which brings together scientific, operational and financial expertise and a successful track record of company creation, value generation and development of new therapeutics that will transform human healthcare.
We focus on highly innovative science and early stage companies developing new approaches to address high unmet medical needs. Eclosion2 fund’s portfolio companies have developed first-in-class drugs with high potential value to patients in fields such as multiple sclerosis, fibrosis or oncology.
We are enablers. Eclosion private investment fund supports portfolio companies from seed to capital stage up to clinical proof of concept, making significant long term operational and financial commitments to companies that have the potential to change the way patients are treated.